HIV vaccine vCP1433
Alternative Names: ALVAC-HIV vCP1433; vCP1433Latest Information Update: 04 Apr 2022
At a glance
- Originator sanofi pasteur
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 18 Jan 2005 Aventis Pasteur is now called sanofi pasteur
- 26 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis
- 31 Jul 2003 Phase-II clinical trials in HIV-1 infections in France (Parenteral)